Sales rise 204.77% to Rs 11.49 crore
Net profit of Concord Drugs declined 33.33% to Rs 0.04 crore in the quarter ended September 2018 as against Rs 0.06 crore during the previous quarter ended September 2017. Sales rose 204.77% to Rs 11.49 crore in the quarter ended September 2018 as against Rs 3.77 crore during the previous quarter ended September 2017. ParticularsQuarter EndedSep. 2018Sep. 2017% Var.Sales11.493.77 205 OPM %8.4425.46 -PBDT0.600.66 -9 PBT0.050.09 -44 NP0.040.06 -33Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
